中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
热门
Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China

文献类型:期刊论文

作者Leung, Ho Wing1,2; Jin, Ling1,2,3; Wei, Si4; Tsui, Mirabelle Mei Po1,2; Zhou, Bingsheng5; Jiao, Liping6,7; Cheung, Pak Chuen1,2; Chun, Yiu Kan1,2; Murphy, Margaret Burkhardt1,2; Lam, Paul Kwan Sing1,2
刊名ENVIRONMENTAL HEALTH PERSPECTIVES
出版日期2013-07-01
卷号121期号:7页码:839-846
关键词China indicator life stage pharmaceuticals risk assessment tap water
ISSN号0091-6765
通讯作者Lam, PKS (reprint author), City Univ Hong Kong, 6213 CYC Bldg,83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
中文摘要BACKGROUND: Pharmaceuticals are known to contaminate tap water worldwide, but the relevant human health risks have not been assessed in China. OBJECTIVES: We monitored 32 pharmaceuticals in Chinese tap water and evaluated the life-long human health risks of exposure in order to provide information for future prioritization and risk management. METHODS: We analyzed samples (n = 113) from 13 cities and compared detected concentrations with existing or newly-derived safety levels for assessing risk quotients (RQs) at different life stages, excluding the prenatal stage. RESULTS: We detected 17 pharmaceuticals in 89% of samples, with most detectable concentrations (92%) at < 50 ng/L. Caffeine (median-maximum, nanograms per liter: 24.4-564), metronidazole (1.8-19.3), salicylic acid (16.6-41.2), clofibric acid (1.2-3.3), carbamazepine (1.3-6.7), and dimetridazole (6.9-14.7) were found in >= 20% of samples. Cities within the Yangtze River region and Guangzhou were regarded as contamination hot spots because of elevated levels and frequent positive detections. Of the 17 pharmaceuticals detected, 13 showed very low risk levels, but 4 (i.e., dimetridazole, thiamphenicol, sulfamethazine, and clarithromycin) were found to have at least one life-stage RQ >= 0.01, especially for the infant and child life stages, and should be considered of high priority for management. We propose an indicator-based monitoring framework for providing information for source identification, water treatment effectiveness, and water safety management in China. CONCLUSION: Chinese tap water is an additional route of human exposure to pharmaceuticals, particularly for dimetridazole, although the risk to human health is low based on current toxicity data. Pharmaceutical detection and application of the proposed monitoring framework can be used for water source protection and risk management in China and elsewhere.
英文摘要BACKGROUND: Pharmaceuticals are known to contaminate tap water worldwide, but the relevant human health risks have not been assessed in China.
WOS标题词Science & Technology ; Life Sciences & Biomedicine
类目[WOS]Environmental Sciences ; Public, Environmental & Occupational Health ; Toxicology
研究领域[WOS]Environmental Sciences & Ecology ; Public, Environmental & Occupational Health ; Toxicology
关键词[WOS]PERSONAL CARE PRODUCTS ; DRINKING-WATER ; WASTE-WATER ; TREATMENT-PLANT ; SURFACE WATERS ; REMOVAL ; ANTIBIOTICS ; ENVIRONMENT ; CONTAMINATION ; INDICATORS
收录类别SCI
资助信息National Natural Science Foundation of China-Research Grants Committee Joint Research Scheme [N_CityU127/12]; NSFC [21007022, 20890113]; Specialized Research Fund for the Doctoral Program of Higher Education [20100091120013]
语种英语
WOS记录号WOS:000323711000024
公开日期2014-01-06
源URL[http://ir.ihb.ac.cn/handle/342005/19596]  
专题水生生物研究所_水环境工程研究中心_期刊论文
作者单位1.City Univ Hong Kong, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China
2.City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China
3.Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld, Australia
4.Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China
5.Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China
6.State Ocean Adm, Inst Oceanog 3, Xiamen, Peoples R China
7.State Ocean Adm, Key Lab Global Change & Marine Atmospher Chem, Xiamen, Peoples R China
推荐引用方式
GB/T 7714
Leung, Ho Wing,Jin, Ling,Wei, Si,et al. Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China[J]. ENVIRONMENTAL HEALTH PERSPECTIVES,2013,121(7):839-846.
APA Leung, Ho Wing.,Jin, Ling.,Wei, Si.,Tsui, Mirabelle Mei Po.,Zhou, Bingsheng.,...&Lam, Paul Kwan Sing.(2013).Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China.ENVIRONMENTAL HEALTH PERSPECTIVES,121(7),839-846.
MLA Leung, Ho Wing,et al."Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China".ENVIRONMENTAL HEALTH PERSPECTIVES 121.7(2013):839-846.

入库方式: OAI收割

来源:水生生物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。